Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy-Reference-Cited by-同舟云学术

Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy

Published:2018-10-26 Issue:46 Volume:10 Page:39455-39467
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

He Xi¹,Cai Kaimin²^ORCID,Zhang Yu¹,Lu Yifei¹,Guo Qin¹,Zhang Yujie¹,Liu Lisha¹,Ruan Chunhui¹,Chen Qinjun¹,Chen Xinli¹,Li Chao¹,Sun Tao¹,Cheng Jianjun²^ORCID,Jiang Chen¹^ORCID

Affiliation:

1. Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Medical Neurobiology, School of Pharmacy, Fudan University, Shanghai 200032, China

2. Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, 1304 W. Green Street, Urbana, Illinois 61801, United States

Funder

National Natural Science Foundation of China

Shanghai Academic Research Leader

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.8b09730

Reference36 articles.

1. Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles

2. Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy